affymetrix inc (AFFX:NASDAQ GS)

Executive Profile*

Background*

Dr. Franklin R. Witney, Frank, Ph.D. has been the Chief Executive Officer and President for Affymetrix Inc. since July 2011. Dr. Witney served as the President and Chief Executive Officer of Dionex Corp., from April 30, 2009 to May 17, 2011. Dr. Witney served as a Senior Vice President of Packard Instrument Company Inc. Dr. Witney served as the President and Chief Executive Officer of Panomics Inc. (formerly, Genospectra Inc.) from July 2002 to December 2008. He served ... as the President and Chief Executive Officer of PerkinElmer Inc. He has 25 years of experience in leadership and innovation in the life science industry. His professional and academic interests have been focused on the biotech and life sciences market throughout his career. He has a tremendous reputation in the life sciences marketplace and as a successful biotech entrepreneur. He has a detailed understanding of genomics and gene regulation for drug targeting and therapeutic research. Dr. Witney served as the Chief Commercial Officer and Executive Vice President of Affymetrix, Inc. from December 2008 to April 2009. Dr. Witney served as President of Drug Discovery Tools division of PerkinElmer Life Sciences, Inc., from November 2001 to July 2002. He was responsible for the reagent and instrument businesses that included high-throughput screening, research products, genomics and proteomics and liquid handling automation at PerkinElmer Life Sciences. He served as the President and Chief Operating Officer of Packard BioScience Co. from April 2000 to November 2001. Dr. Witney served as the President of Packard Instrument Company Inc. since October 2000. At Packard, he was responsible for its global operations, including research and development, manufacturing, marketing, and worldwide sales. From 1983 to 2000, he held a series of management positions at Bio-Rad Laboratories, where he served as Group Operations Manager of Life Sciences from July 1997 to April 2000. Dr. Witney was responsible for the development and execution of the strategic plan and the performance of Packard Instrument Company, CCS Packard Inc., Packard BioScience B.V., BioSignal Packard, Inc. and Packard Bioscience Co.'s international sales subsidiaries. Dr. Witney has been Director of Applied Precision Inc. since December 2005. He has been a Director of Affymetrix Inc. since July 01, 2011. He serves as a Director of DVS Sciences Inc. and Panomics Inc. He serves as a Director of One Lambda, Inc. He served as Director of PerkinElmer Inc. He served as Director of Dionex Corp. from April 30, 2009 to May 17, 2011. He served as Director of Transgenomic Inc. from April 18, 2007 to May 20, 2009. He has authored more than 15 papers on molecular biology and biochemistry and holds seven patents. Dr. Witney holds a B.S. in Microbiology from the University of Illinois and an M.S. in Microbiology and a doctorate (Ph.D.) in Molecular and Cellular Biology from Indiana University. He was a post-doctoral fellow at the National Institutes of Health.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
AFFX:US	$3.73 USD	+0.06

COMPETITOR COMPENSATION